Shield to acquire Echodyne in $5.3 billion transaction; raises $2.5 billion at $28.8 billion valuation
BX•BX•BX•BX•Shield will acquire Echodyne in a transaction valued at $5.3 billion and raise $2.5 billion at a $28.8 billion valuation. The raise includes a $1 billion structured equity investment from funds managed by Blackstone and $500 million in debt financing led by JPMorgan Chase Bank.
Shield will acquire Echodyne in a transaction valued at $5.3 billion and raise $2.5 billion to support the deal, including $1 billion in Series H funding. Funds managed by Blackstone will provide a $1 billion structured equity investment, while $500 million in debt financing will be led by JPMorgan Chase Bank as sole arranger.
Up to an additional $500 million of the transaction value is contingent on Echodyne meeting agreed performance targets. The Series H funding is co-led by Disruptive and Innovation X Capital.
